Loratadine Allergy Relief
NDC 10135-763, Loratadine, tablet, from Marlex Pharmaceuticals, Inc..
- Product NDC
- 10135-763
- Status
- Listed
- Labeler
- Marlex Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA076134
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-763 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LORATADINE10 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-763-03 | 10135076303 | 300 TABLET in 1 BOTTLE (10135-763-03) |
| 10135-763-30 | 10135076330 | 30 TABLET in 1 BOTTLE (10135-763-30) |
| 10135-763-90 | 10135076390 | 90 TABLET in 1 BOTTLE (10135-763-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 10135-763 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-763 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-763. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.